Digest Network Come funziona
Network
/
Società
EN
Non verificato

ENDRA Life Sciences Inc.

Di cosa scriviamo

Attrezzature medico-sanitarieMedicina - VarieMedicina nucleareSaluteScienza

27 comunicati stampa

Guarda tutti i comunicati
18/05/2026
Mercato azionario
Industria
Scienza
Attrezzature medico-sanitarie
Medicina - Varie
Biotecnologia
Medicina nucleare
Salute
Farmaceutica
ENDRA Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update
Fonte
ENDRA Life Sciences Inc.
Emittente
Business Wire
1.00
0
14/05/2026
Industria
Salute
Attrezzature medico-sanitarie
Medicina - Varie
Scienza
Farmaceutica
ENDRA Life Sciences Reports Multi-Site Validation of TAEUS® Liver Device Demonstrating MRI-like Accuracy and Reproducibility
Fonte
ENDRA Life Sciences Inc.
Emittente
Business Wire
1.00
0
31/03/2026
Mercato azionario
Attrezzature medico-sanitarie
Salute
Medicina - Varie
Sanità
Medicina nucleare
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Fonte
ENDRA Life Sciences Inc.
Emittente
Business Wire
1.00
0
25/03/2026
Salute
Attrezzature medico-sanitarie
Tecnica
Tecnologie Varie
Sanità
Biotecnologia
ENDRA Life Sciences Initiates Review of Strategic Alternatives to Maximize Shareholder Value
Fonte
ENDRA Life Sciences Inc.
Emittente
Business Wire
1.00
0
26/02/2026
Industria
Scienza
Attrezzature medico-sanitarie
Biotecnologia
Medicina - Varie
Medicina nucleare
Farmaceutica
Salute
ENDRA’s TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care
Fonte
ENDRA Life Sciences Inc.
Emittente
Business Wire
1.00
0
04/12/2025
Industria
Salute
Farmaceutica
Medicina - Varie
ENDRA’s TAEUS® Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use
Fonte
ENDRA Life Sciences Inc.
Emittente
Business Wire
1.00
0
20/11/2025
Industria
Scienza
Medicina nucleare
Biotecnologia
Salute
Attrezzature medico-sanitarie
Medicina - Varie
ENDRA Feasibility Study Demonstrates TAEUS® Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH Biomarker
Fonte
ENDRA Life Sciences Inc.
Emittente
Business Wire
1.00
0
17/11/2025
Salute
Sanità
Medicina - Varie
Scienza
Biotecnologia
Mercato azionario
ENDRA Life Sciences Recaps Major Milestones and New Strategic Initiatives, Announces Third Quarter 2025 Financial Results
Fonte
ENDRA Life Sciences Inc.
Emittente
Business Wire
1.00
0
13/11/2025
Sanità
Associazioni/Professionisti
Medicina nucleare
Tecnica
Biotecnologia
Attrezzature medico-sanitarie
Salute
ENDRA Life Sciences Commences Staking of HYPE Digital Asset Holdings, Reinforcing Long-Term Strategy with Anchorage Digital and ARCA
Fonte
ENDRA Life Sciences Inc.
Emittente
Business Wire
1.00
0
23/10/2025
Sanità
Medicina nucleare
Associazioni/Professionisti
Attrezzature medico-sanitarie
Tecnica
Tecnologie Varie
Salute
ENDRA Life Sciences Closes Up to $14.4 Million Private Placement and Launches Crypto Treasury Strategy with $3 Million in Initial HYPE Token Holdings
Fonte
ENDRA Life Sciences Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0